Effects of a New Oral Contraceptive Containing an Antimineralocorticoid Progestogen, Drospirenone, on the Renin-Aldosterone System, Body Weight, Blood Pressure, Glucose Tolerance, and Lipid Metabolism.

Journal of Clinical Endocrinology and Metabolism - United States
doi 10.1210/jcem.80.6.7775629

Related search